Literature DB >> 2006471

Risk factors for birth defects: data from the Atlanta Birth Defects Case-Control Study.

J D Erickson1.   

Abstract

The Atlanta Birth Defects Case-Control Study data comprises information obtained from interviews with parents of 4,900 babies born with major birth defects and with the parents of 3,000 babies born without defects. The source of cases is the Centers for Disease Control's Metropolitan Atlanta Congenital Defects program; the case-control study is population-based. Birth defects are classified into 92 groups and cross-tabulated by 105 exposure/risk factor variables; data from selected cross-tabulations are presented. The associations of each of the 105 exposure variables with all types of defects combined are presented, as are the associations of each of the 92 defect groups with the specific exposure variable, maternal diabetes. These data can be used to evaluate hypotheses arising from other sources, and for the purpose of "generating" hypotheses. The data describing all 92 x 105 cross-tabulations are available to other investigators on floppy disk; write to Chief, Birth Defects and Genetic Diseases Branch, Centers for Disease Control, Atlanta, Georgia 30333.

Entities:  

Mesh:

Year:  1991        PMID: 2006471     DOI: 10.1002/tera.1420430106

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  18 in total

Review 1.  Methodological problems and the role of statistics in cluster response studies: a framework.

Authors:  P K Quataert; B Armstrong; A Berghold; F Bianchi; A Kelly; M Marchi; M Martuzzi; A Rosano
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

2.  Editorial perspectives from the founding CDC leadership of the National Birth Defects Prevention study.

Authors:  Cynthia A Moore; Paula W Yoon; Larry D Edmonds; J David Erickson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-10

3.  Original Findings and Updated Meta-Analysis for the Association Between Maternal Diabetes and Risk for Congenital Heart Disease Phenotypes.

Authors:  Thanh T Hoang; Lisa K Marengo; Laura E Mitchell; Mark A Canfield; A J Agopian
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

4.  Vasoactive exposures during pregnancy and risk of microtia.

Authors:  Carla M Van Bennekom; Allen A Mitchell; Cynthia A Moore; Martha M Werler
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-11-24

5.  Corticosteroid use during pregnancy and risk of orofacial clefts.

Authors:  Anders Hviid; Ditte Mølgaard-Nielsen
Journal:  CMAJ       Date:  2011-04-11       Impact factor: 8.262

6.  The National Birth Defects Prevention Study.

Authors:  P W Yoon; S A Rasmussen; M C Lynberg; C A Moore; M Anderka; S L Carmichael; P Costa; C Druschel; C A Hobbs; P A Romitti; P H Langlois; L D Edmonds
Journal:  Public Health Rep       Date:  2001       Impact factor: 2.792

Review 7.  A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors:  P Mazzotta; L A Magee
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

8.  First trimester exposure to antiretroviral therapy and risk of birth defects.

Authors:  Kelesitse Phiri; Sonia Hernandez-Diaz; Kate B Dugan; Paige L Williams; Judith A Dudley; Astride Jules; S Todd Callahan; George R Seage; William O Cooper
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

9.  Proportion of selected congenital heart defects attributable to recognized risk factors.

Authors:  Regina M Simeone; Sarah C Tinker; Suzanne M Gilboa; A J Agopian; Matthew E Oster; Owen J Devine; Margaret A Honein
Journal:  Ann Epidemiol       Date:  2016-10-26       Impact factor: 3.797

10.  Association of Maternal Prepregnancy Diabetes and Gestational Diabetes Mellitus With Congenital Anomalies of the Newborn.

Authors:  Yuxiao Wu; Buyun Liu; Yangbo Sun; Yang Du; Mark K Santillan; Donna A Santillan; Linda G Snetselaar; Wei Bao
Journal:  Diabetes Care       Date:  2020-10-21       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.